semaglutide lawsuit 2025 Novo Nordisk A/S (NVO) Securities Class Action Update Semaglutide Shortage Ends: Compounded Versions

Baseline characteristics included a mean age of 48 years, 71% female, 72% White, 14% Asian, 9% Black or African American, and 5% reported as other or unknown

Retrieved from Brotto, L., Atallah, S., Johnson-Agbakwu, C., et al

Gastroenterology 126 , 629630 (2004)

Insulin Therapy & GLP-1 Analogues in Type 2 Diabetes Mellitus An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author

Key Insight : The total GLP-1 spend per member per month has more than tripled from $5.29 in 2020 to $18.27 in 2023 , indicating a rapid and significant shift in healthcare spending patterns